Faculty

The Gerstner Sloan Kettering faculty brings together outstanding scientists and engineers working at the forefront of biomedical research and cancer engineering. Browse our list of Faculty and learn more about each faculty member’s area of investigation.

Faculty members who do not serve as dissertation mentors but who make contributions to the education of our students by teaching or serving as clinical mentors are appointed as Gerstner Sloan Kettering Special Contributing Faculty.

and/or
139 Faculty Members found
The Alexander Rudensky Lab
Immunology Program
Immunology Program Chair Alexander Rudensky focuses on immunological tolerance and the differentiation and function of T cells.
  • PhD, Gabrichevsky Institute for Microbiology and Epidemiology
The Charles Rudin Lab
Memorial Hospital Research Laboratories
Physician-scientist Charles Rudin focuses on the development and testing of novel therapeutic approaches to lung cancer in preclinical models.
  • MD, PhD, University of Chicago Pritzker School of Medicine
The Charles Sawyers Lab
Human Oncology & Pathogenesis Program
Human Oncology and Pathogenesis Program Chair Charles Sawyers develops molecularly targeted cancer therapy.
  • MD, Johns Hopkins University School of Medicine
The David Scheinberg Lab
Molecular Pharmacology Program
Molecular Pharmacology Program Member David Scheinberg focuses on the discovery and development of novel, specific immunotherapeutic agents and targeted nanodevices for cancer therapy.
  • MD, PhD, Johns Hopkins University School of Medicine
Andrea Schietinger lab
Immunology Program
Cancer Immunologist Andrea Schietinger investigates immune responses to cancer, molecular mechanisms underlying tumor-induced T cell dysfunction, and new approaches for cancer immunotherapy.
  • PharmD, University of Hamburg, PhD, University of Chicago, Chicago, IL and University of Munich, Germany
  • Postdoctoral Training: Fred Hutchinson Cancer Research Center and University of Washington, Seattle
Nikolaus Schultz Lab
Epidemiology & Biostatistics
Cancer biologist Nikolaus Schultz uses computational tools to study the diversity of genomic alterations underlying different cancer types.
  • PhD, Freie Universitat Berlin
Molecular Biology Program
Agnel Sfeir, PhD
Professor
The Sfeir Lab investigates pathways that ensure genome fidelity and plasticity.
  • PhD, UT Southwestern Medical Center, Texas (2006)
  • Post-Doc, The Rockefeller University, New York (2011)
Sohrab Shah Lab Group
Epidemiology & Biostatistics
Sohrab Shah, PhD
Professor
The Shah lab focuses on the major topics of cancer evolution, single cell genomics and transcriptomics, mutational processes and prediction of drug response.
  • PhD, University of British Columbia (Canada)
Epidemiology & Biostatistics
Ronglai Shen, PhD
Professor
My research has focused on the development of novel statistical and bioinformatic methodologies that facilitate the study of translational research questions in cancer genomics and immuno-oncology.
  • PhD, University of Michigan, Ann Arbor, MI
Cancer Biology & Genetics Program
Mara Sherman, PhD
Associate Professor
The Mara Sherman lab aims to understand the heterocellular interactions among pancreatic cancer cells and their surrounding microenvironment, and to target these networks for therapeutic benefit.
  • PhD, University of California, Los Angeles